Kuehn Law, PLLC is investigating whether officers and directors of Travere Therapeutics breached their fiduciary duties through potential self-dealing. This probe could lead to damages for shareholders and corporate governance reforms. Long-term shareholders are encouraged to contact the law firm to protect their rights. The investigation highlights concerns about management integrity and shareholder value at Travere Therapeutics.
Bank of Hawaii Corporation reported a strong Q2 earnings per share (EPS) of $1.47, surpassing analyst expectations and marking growth from both the previous quarter and last year. However, its revenue of $184.85 million fell short of the estimated $1...
F5, Inc., a leader in application security solutions, will announce its Q2 2026 earnings on July 27 after market close. Revenue is projected at about $834.60 million, up from $780.37 million a year ago, with earnings per share expected around $4.00, ...
State Street Global Advisors & Affiliates disclosed an increase in their holding of DCC plc shares to 1.42%, following recent purchases of 338 shares at €62.85 each and sales of 96 shares at the same price. This disclosure is part of regulatory requi...
Cint has expanded its partnership with Samba to include brand lift measurement for TV campaigns in six additional international markets: Australia, Canada, France, Germany, Italy, and Spain. This expansion allows advertisers to use Samba’s determinis...
Celestica, a key supplier in AI infrastructure, continues to show strong financial performance with a 52.8% revenue increase in Q1 and five consecutive earnings beats. Driven by high demand in its Connectivity and Cloud Solutions segment, the company...
